Raleigh Capital Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3
| Closed | -$672 | – | 711 |
|
|
2025
Q1 | $672 | Sell |
3
-19
| -86% | -$4.26K | ﹤0.01% | 472 |
|
|
2024
Q4 | $7.21K | Buy |
22
+1
| +5% | +$328 | ﹤0.01% | 660 |
|
|
2024
Q3 | $6.3K | Buy |
21
+14
| +200% | +$4.2K | ﹤0.01% | 668 |
|
|
2024
Q2 | $2.31K | Sell |
7
-1
| -13% | -$329 | ﹤0.01% | 768 |
|
|
2024
Q1 | $3.17K | Sell |
8
-81
| -91% | -$32.1K | ﹤0.01% | 713 |
|
|
2023
Q4 | $31.4K | Buy |
89
+7
| +9% | +$2.47K | 0.01% | 351 |
|
|
2023
Q3 | $30.8K | Buy |
82
+2
| +3% | +$751 | 0.02% | 320 |
|
|
2023
Q2 | $30.6K | Buy |
+80
| New | +$30.6K | 0.02% | 303 |
|